Artwork

Conteúdo fornecido por The PJ Pod and Pharmaceutical Journal. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por The PJ Pod and Pharmaceutical Journal ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
Player FM - Aplicativo de podcast
Fique off-line com o app Player FM !

COVID-19 vaccines: your questions answered

34:27
 
Compartilhar
 

Manage episode 323237398 series 3329558
Conteúdo fornecido por The PJ Pod and Pharmaceutical Journal. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por The PJ Pod and Pharmaceutical Journal ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
We asked PJ readers to submit their questions regarding the different COVID-19 vaccines being developed around the world, the phase III trial results and the practicalities of how these vaccines will be administered. In this podcast, Dawn Connelly, features editor and Julia Robinson, clinical and science editor, will try to answer these questions using the latest available information and the help of some external experts. Thanks to Charles Bangham, chair in immunology and co-director of the Institute of Infection at Imperial College London and Stephen Evans, professor of pharmacoepidemiology at the London School of Hygiene and Tropical Medicine. A link to the infographic referred to in the podcast is here: https://www.pharmaceutical-journal.com/news-and-analysis/infographics/the-race-to-stop-covid-19/20207792.article Please do let us know if you have any outstanding questions regarding the COVID vaccines after listening to this podcast. Email us at dawn.connelly@rpharms.com — if there are enough, we may do another podcast! This podcast is presented by Nigel Praities, Dawn Connelly and Julia Robinson. It was produced by Geoff Marsh.
  continue reading

48 episódios

Artwork
iconCompartilhar
 
Manage episode 323237398 series 3329558
Conteúdo fornecido por The PJ Pod and Pharmaceutical Journal. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por The PJ Pod and Pharmaceutical Journal ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
We asked PJ readers to submit their questions regarding the different COVID-19 vaccines being developed around the world, the phase III trial results and the practicalities of how these vaccines will be administered. In this podcast, Dawn Connelly, features editor and Julia Robinson, clinical and science editor, will try to answer these questions using the latest available information and the help of some external experts. Thanks to Charles Bangham, chair in immunology and co-director of the Institute of Infection at Imperial College London and Stephen Evans, professor of pharmacoepidemiology at the London School of Hygiene and Tropical Medicine. A link to the infographic referred to in the podcast is here: https://www.pharmaceutical-journal.com/news-and-analysis/infographics/the-race-to-stop-covid-19/20207792.article Please do let us know if you have any outstanding questions regarding the COVID vaccines after listening to this podcast. Email us at dawn.connelly@rpharms.com — if there are enough, we may do another podcast! This podcast is presented by Nigel Praities, Dawn Connelly and Julia Robinson. It was produced by Geoff Marsh.
  continue reading

48 episódios

Semua episod

×
 
Loading …

Bem vindo ao Player FM!

O Player FM procura na web por podcasts de alta qualidade para você curtir agora mesmo. É o melhor app de podcast e funciona no Android, iPhone e web. Inscreva-se para sincronizar as assinaturas entre os dispositivos.

 

Guia rápido de referências